Literature DB >> 1078551

Letter: Limitations of methotrexate and citrovorum-factor treatments.

E Frei, N J Jaffe, S Pitman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1078551     DOI: 10.1056/NEJM197501092920216

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  The utility of online haemodiafiltration in methotrexate poisoning.

Authors:  Mohamed Said Abdelsalam; Mohammed Mahdi Althaf; Osman Alfurayh; Irfan Maghfoor
Journal:  BMJ Case Rep       Date:  2014-05-23

2.  Pharmacokinetics of high-dose methotrexate treatment in children.

Authors:  D Bratlid; P J Moe
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

3.  Early, empiric high-dose leucovorin rescue in lymphoma patients treated with sequential doses of high-dose methotrexate.

Authors:  Jason N Barreto; Kristen T Peterson; Erin F Barreto; Kristin C Mara; Ross A Dierkhising; Nelson Leung; Thomas E Witzig; Carrie A Thompson
Journal:  Support Care Cancer       Date:  2021-03-04       Impact factor: 3.603

4.  Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Marc Ghannoum; Darren M Roberts; David S Goldfarb; Jesper Heldrup; Kurt Anseeuw; Tais F Galvao; Thomas D Nolin; Robert S Hoffman; Valery Lavergne; Paul Meyers; Sophie Gosselin; Tudor Botnaru; Karine Mardini; David M Wood
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-02       Impact factor: 10.614

5.  Competitive protein binding assay for methotrexate.

Authors:  C E Myers; M E Lippman; H M Elliot; B A Chabner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.